BRADLEY FOSTER & SARGENT INC/CT

Position in CGTX — Cognition Therapeutics Inc

CIK 1015086 HARTFORD, CT

Position in CGTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$13,480

+$4,572 QoQ

Shares Held

11,722

0.0% QoQ

Ownership

0.012%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#49

of 66 holders

Holding Since

Mar 2025

6 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BRADLEY FOSTER & SARGENT INC/CT holds $1,337,687 across 4 Biotechnology names. CGTX ranks #4 (1.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,286	$638,794
2	ALNY	Alnylam Pharmaceuticals, Inc.	1,351	$406,691
3	REGN	Regeneron Pharmaceuticals, Inc.	447	$278,722
4	CGTX	Cognition Therapeutics Inc This page	11,722	$13,480

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$13,480	11,722	0.0%	Shares	Sole	2026-08-14
2026-03-31	$8,908	11,722	0.0%	Shares	Sole	2026-05-15
2025-12-31	$15,824	11,722	0.0%	Shares	Sole	2026-02-12
2025-09-30	$15,824	11,722	0.0%	Shares	Sole	2025-11-10
2025-06-30	$3,633	11,722	0.0%	Shares	Sole	2025-08-11
2025-03-31	$4,934	11,722	—	Shares	Sole	2025-05-13
No filing history on record for this holder in this stock.